Tissue microarray evaluation of melanoma antigen E (MAGE) tumor-associated antigen expression: Potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma

Annals of Surgery

Volumn 236, Issue 6, 2002, Pages 785-793

  Bolli, Martin ^a   Kocher, Thomas ^a   Adamina, Michel ^a   Guller, Ulrich ^a   Dalquen, Peter ^a   Haas, Philippe ^a   Mirlacher, Martina ^a   Gambazzi, Franco ^a   Harder, Felix ^a   Heberer, Michael ^a   Sauter, Guido ^a   Spagnoli, Giulio C ^a   Buchler, M W ^b   Mendes de Almeida, J M ^b   O'Sullivan, G C ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b University Hospital Basel ^*

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN E; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TESTIS;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CULTURE TECHNIQUES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036894242     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200212000-00011     Document Type: Article

References (29)

1. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254:1643-1647.
2. Jungbluth AA, Busam KJ, Kolb D, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 2000; 85:460-465.
3. Chomez P, De Backer O, Bertrand M, et al. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001; 61:5544-5551.
4. Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183:725-730.
5. Duffour MT, Chaux P, Lurquin C, et al. A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes. Eur J Immunol 1999; 29:3329-3337.
6. Renkvist N, Castelli C, Robbins PF, et al. A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 2001; 50:3-15.
7. Marchand M, van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999; 80:219-230.
8. Schuler-Thurner B, Dieckmann D, Keikavoussi P, et al. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1 + melanoma patients by mature monocyte-derived dendritic cells. J Immunol 2000; 165:3492-3496.
9. Landry C, Brasseur F, Spagnoli GC, et al. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 2000; 86:835-841.
10. van Baren N, Brasseur F, Godelaine D, et al. Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood 1999; 94:1156-1164.
11. Chambost H, Van Baren N, Brasseur F, et al. Expression of gene MAGE-A4 in Reed-Sternberg cells. Blood 2000; 95:3530-3533.
12. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-847.
13. Kocher T, Schultz-Thater E, Gudat F, et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res 1995; 55:2236-2239.
14. Gudat F, Zuber M, Durmuller U, et al. The tumour-associated antigen MAGE-1 is detectable in formalin-fixed paraffin sections of malignant melanoma. Virchows Arch 1996; 429:77-81.
15. Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000; 157:787-794.
16. Kallioniemi O, Wagner U, Kononen J, et al. Tissue microarray technology for high throughput molecular profiling of cancer. Hum Mol Genet 2001; 10:657-662.
17. Sobin LH, Wittekind C, eds. IUCC TNM Classification of Malignant Tumors, 6th Ed. New York: John Wiley & Sons, 2002.
18. Cox D. Regression models and life tables. J R Stat Soc 1972; 34:187-220.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
20. Fischer C, Gudat F, Stulz P, et al. High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int J Cancer 1997; 71:1119-1121.
21. Sadanaga N, Nagashima H, Mashino K, et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res 2001; 7:2277-2284.
22. Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999; 5:1966-1975.
23. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40:360-369.
24. Aubry F, Satie AP. Rioux-Leclercq N, et al. MAGE-A4, a germ cell specific marker is expressed differentially in testicular tumors. Cancer 2001; 92:2778-2785.
25. Hofbauer GFL, Schaefer C, Noppen C, et al. MAGE-3 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma. Am J Pathol 1997; 151:1549-1553.
26. Patard JJ, Brasseur F, Gil-Diez S, et al. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 1995; 64:60-64.
27. Jang SJ, Soria JC, Wang L, et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 2001; 61:7959-7963.
28. Weber J, Salgaller M, Samid D, et al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2"-deoxycytidine. Cancer Res 1994; 54:1766-1771.
29. Janssen BL, van de Locht LT, Fourkour A, et al. Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: A quantitative analysis in melanoma cell lines using a realtime polymerase chain reaction technique. Melanoma Res 1999; 9:213-222.